Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan
· Delayed Price · Currency is TWD 41.25
-0.25 (-0.60%)
At close: Dec 4, 2025
Senhwa Biosciences Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -263.96 | -293.75 | -296.31 | -349.63 | -329.26 | -354.88 | Upgrade
|
| Depreciation & Amortization | 12.08 | 12.1 | 10.73 | 7.11 | 6.23 | 7.11 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.67 | -8.68 | -8.04 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | -0.64 | 1.03 | 3.47 | 51.45 | Upgrade
|
| Other Operating Activities | -1.38 | -0.72 | -1.07 | -0.25 | -7.91 | 0.22 | Upgrade
|
| Change in Accounts Receivable | 9.9 | 9.99 | -9.87 | 0.19 | -0.19 | 0.03 | Upgrade
|
| Change in Accounts Payable | -6.62 | -10.83 | 9.74 | -52.3 | 27.19 | 26.23 | Upgrade
|
| Change in Other Net Operating Assets | -1.86 | -2.34 | 1.07 | -6.12 | 0.41 | -2.84 | Upgrade
|
| Operating Cash Flow | -258.5 | -294.22 | -294.4 | -399.97 | -300.05 | -272.68 | Upgrade
|
| Capital Expenditures | - | -1.95 | -4.61 | -0.37 | -0.24 | -0.39 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.17 | - | -0.16 | - | Upgrade
|
| Investment in Securities | 6.67 | 8.68 | 8.04 | - | - | - | Upgrade
|
| Other Investing Activities | -0.06 | -0.02 | -0.48 | -0.22 | 0.55 | 0.01 | Upgrade
|
| Investing Cash Flow | 6.6 | 6.71 | 2.79 | -0.59 | 0.15 | -0.38 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 9.63 | Upgrade
|
| Long-Term Debt Repaid | - | -8.73 | -8.83 | -6.31 | -4.93 | -5.6 | Upgrade
|
| Net Debt Issued (Repaid) | -9.32 | -8.73 | -8.83 | -6.31 | -4.93 | 4.03 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 6.81 | 1,807 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -13.24 | -36.12 | -1.99 | Upgrade
|
| Financing Cash Flow | -9.32 | -8.73 | -8.83 | -19.55 | -34.24 | 1,809 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.02 | 3.4 | 0.11 | 6.67 | -1.85 | -4.29 | Upgrade
|
| Net Cash Flow | -263.24 | -292.84 | -300.33 | -413.44 | -336 | 1,531 | Upgrade
|
| Free Cash Flow | -258.5 | -296.17 | -299 | -400.34 | -300.29 | -273.07 | Upgrade
|
| Free Cash Flow Margin | -23935.46% | -29617.30% | -29900.10% | -40034.00% | -54597.64% | -44257.86% | Upgrade
|
| Free Cash Flow Per Share | -2.89 | -3.32 | -3.35 | -4.49 | -3.35 | -3.46 | Upgrade
|
| Cash Interest Paid | 0.69 | 0.66 | 0.54 | 0.54 | 0.53 | 0.19 | Upgrade
|
| Cash Income Tax Paid | 1.76 | 1.62 | 1.87 | 1.36 | -1.32 | 0.41 | Upgrade
|
| Levered Free Cash Flow | -147.86 | -185.82 | -176.66 | -273.62 | -177.76 | -142.89 | Upgrade
|
| Unlevered Free Cash Flow | -147.43 | -185.41 | -176.33 | -273.28 | -177.43 | -142.73 | Upgrade
|
| Change in Working Capital | 1.43 | -3.17 | 0.94 | -58.23 | 27.42 | 23.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.